Exodus Point Capital Management, LP Syndax Pharmaceuticals Inc Transaction History

Exodus Point Capital Management, LP

$9.1 Billion
Q3 2025

A detailed history of Exodus Point Capital Management, LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 72,464 shares of SNDX stock, worth $1.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

72,464

Holding current value

$1.2 Million

% of portfolio

0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$8.73 - $17.04 $632,610 - $1.23 Million	72,464 New	72,464 $1.12 Million
Q1 2025 May 14, 2025	BUY	$12.29 - $16.38 $2.04 Million - $2.72 Million	165,839 Added 111.62%	314,407 $3.86 Million
Q4 2024 Feb 12, 2025	SELL	$12.52 - $21.81 $2.13 Million - $3.7 Million	-169,826 Reduced 53.34%	148,568 $1.96 Million
Q3 2024 Nov 12, 2024	SELL	$17.93 - $24.81 $5.51 Million - $7.62 Million	-307,329 Reduced 49.12%	318,394 $6.13 Million
Q2 2024 Aug 13, 2024	BUY	$18.82 - $23.79 $6.39 Million - $8.07 Million	339,393 Added 118.53%	625,723 $12.8 Million

Q1 2024 May 14, 2024	BUY	$19.71 - $24.57 $2.57 Million - $3.21 Million	130,616 Added 83.88%	286,330 $6.82 Million
Q3 2023 Nov 09, 2023	SELL	$14.52 - $21.77 $726,058 - $1.09 Million	-50,004 Reduced 24.31%	155,714 $2.26 Million
Q2 2023 Aug 10, 2023	BUY	$19.35 - $22.31 $2.78 Million - $3.21 Million	143,845 Added 232.48%	205,718 $4.31 Million
Q1 2023 May 11, 2023	BUY	$20.66 - $28.98 $1.28 Million - $1.79 Million	61,873 New	61,873 $1.31 Million
Q3 2022 Nov 10, 2022	SELL	$18.51 - $24.79 $35,002 - $46,877	-1,891 Reduced 3.13%	58,466 $1.41 Million
Q2 2022 Aug 19, 2022	BUY	$13.64 - $19.48 $554,929 - $792,524	40,684 Added 206.8%	60,357 $1.16 Million
Q1 2022 May 13, 2022	BUY	$14.84 - $22.15 $291,947 - $435,756	19,673 New	19,673 $342,000
Q2 2021 Aug 16, 2021	SELL	$13.42 - $25.18 $139,017 - $260,839	-10,359 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$19.28 - $24.59 $199,721 - $254,727	10,359 New	10,359 $232,000

Others Institutions Holding SNDX

# of Institutions

253

Shares Held

99.8M

Call Options Held

1.41M

Put Options Held

737K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $940M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Syndax Pharmaceuticals Inc Transaction History